Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

6.37
Delayed Data
As of 4:00pm ET
 +0.40 / +6.70%
Today’s Change
1.82
Today|||52-Week Range
6.41
+72.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-34.6M-43.0M-36.7M-38.0M
 
 
 
 
 
Depreciation20.0K29.0K27.0K11.0K
 
 
 
 
 
Total Other Cash Flow4.3M2.7M2.9M5.2M
 
 
 
 
 
Funds From Operations-30.3M-40.3M-33.7M-32.8M
 
 
 
 
 
Funds From/For Other Operating Expenses7.1M2.9M5.0M4.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-37.4M-43.2M-38.7M-37.0M
 
 
 
 
 
 
InvestingIncrease In Investments-26.9M-42.5M-35.7M-35.5M
 
 
 
 
 
Decrease In Investments59.1M45.8M36.9M20.5M
 
 
 
 
 
Capital Expenditures0.00-48.0K0.000.00
 
 
Net Cash Flow Investing32.2M3.3M1.2M-15.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings0.000.000.0014.7M
 
 
Long Term Debt Reduction-7.2M-9.4M-1.6M-8.0M
 
 
 
 
 
Net Proceeds Stock Sale12.6M56.3M43.8M26.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing5.4M46.9M42.2M33.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash181.0K7.1M4.7M-18.8M